Arab Board Oncology Clinical case studies
Arab Board Oncology Clinical · Put your knowledge to work in context.
The Arab Board of Health Specializations Oncology (Clinical) examination is a specialty board credential for physicians who have completed oncology training and are seeking recognition to practise as clinical oncologists within the Arab region. It is aimed at candidates who already hold a primary medical degree plus accredited residency or fellowship training, and who are preparing to sit the final specialty assessment. The Arab Board Oncology Clinical case studies are 5 cases and about 2,290 words.
1Neoadjuvant Therapy Decision in Locally Advanced Rectal Cancer with a Narrow Distal Margin
A 58-year-old man presents with a T3N1 mid-to-low rectal adenocarcinoma 5 cm from the anal verge, circumferential margin threatened on MRI (2 mm), and no distant disease on CT chest/abdomen/pelvis. He has well-controlled hypertension and no prior pelvic surgery or radiation.
509 words, about 3 min2Febrile Neutropenia in a Patient on Palliative Chemotherapy in a Resource-Limited Setting
A 64-year-old woman with metastatic pancreatic adenocarcinoma on gemcitabine plus nab-paclitaxel presents on day 9 of cycle 2 with fever of 38.6°C, rigors, and hypotension (BP 88/54 mmHg). She lives 3 hours from the cancer center, has no caregiver at home, and her local hospital has no oncology service but does have a general ICU and can give intravenous antibiotics.
509 words, about 3 min3Adjuvant Treatment in a Young Woman with Early Breast Cancer and a Pathogenic BRCA1 Variant
A 34-year-old premenopausal woman undergoes breast-conserving surgery and sentinel node biopsy for a 2.2 cm grade 3 invasive ductal carcinoma. Pathology: ER 5%, PR 0%, HER2-negative (triple-negative), one micrometastasis in the sentinel node (0.3 mm), margins clear.
415 words, about 2 min4Immune-Related Adverse Events After First-Line Immunotherapy for Metastatic NSCLC
A 67-year-old former smoker with metastatic lung adenocarcinoma (PD-L1 TPS 70%, no driver mutations) began pembrolizumab monotherapy 3 weeks ago. He now presents with 4 days of progressive dyspnea, a dry cough, and fatigue.
430 words, about 2 min5Interpretation of a Screening Trial Before Changing Practice
A hospital committee is asked to adopt annual low-dose CT (LDCT) lung cancer screening for all smokers. They cite a trial in which LDCT reduced lung cancer mortality by 20% (relative) in high-risk smokers aged 55–74 with at least 30 pack-years.
427 words, about 2 min